Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain.
Juan Antonio Castillo-PoloMarta Hernandez-GarcíaMaría Isabel MorosiniBlanca Pérez-VisoCruz SorianoRaúl De PabloRafael CantónPatricia Ruiz-GarbajosaPublished in: The Journal of antimicrobial chemotherapy (2023)
The emergence of resistance to both ceftazidime/avibactam and cefiderocol in KPC-Kp-HRCs, together with the diversification of novel KPC enzymes displaying different antibiotic resistance phenotypes, is an epidemiological and clinical risk.